| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,420,214 |
|
|
|
Indirect Value
|
$116,216 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,536,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2016-05-19 |
4 |
B |
$1.18 |
$50,875 |
D/D |
43,169 |
1,863,000 |
2.39 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-05-20 |
4/A |
B |
$1.20 |
$6,764 |
D/D |
5,637 |
1,688,637 |
3.84 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2016-05-20 |
4 |
B |
$1.20 |
$6,764 |
D/D |
5,637 |
1,868,637 |
2.39 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-06-08 |
4/A |
B |
$1.24 |
$62,000 |
D/D |
50,000 |
1,738,637 |
3.92 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-06-08 |
4 |
B |
$1.24 |
$62,000 |
D/D |
50,000 |
1,918,637 |
3.92 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-06-21 |
4 |
B |
$2.00 |
$100,000 |
D/D |
50,000 |
430,724 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-06-24 |
4 |
B |
$3.70 |
$184,845 |
D/D |
50,000 |
381,440 |
2.39 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-08-18 |
4 |
B |
$0.99 |
$24,750 |
D/D |
25,000 |
1,763,637 |
3.92 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-09-13 |
4 |
B |
$0.79 |
$79,180 |
D/D |
100,000 |
530,724 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
630,724 |
2.31 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-11-23 |
4 |
B |
$0.41 |
$48,600 |
I/I |
120,000 |
120,000 |
2.1 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2018-01-29 |
4 |
B |
$10.00 |
$900,000 |
D/D |
90,000 |
236,770 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2018-06-25 |
4 |
B |
$4.48 |
$73,920 |
I/I |
16,500 |
50,000 |
2.1 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-02-12 |
4 |
B |
$89.99 |
$179,980 |
I/I |
2,000 |
2,000 |
0.01 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-07-11 |
4 |
B |
$2.78 |
$99,999 |
D/D |
35,971 |
272,741 |
2.39 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-03-24 |
4 |
B |
$2.27 |
$187,118 |
D/D |
82,431 |
327,239 |
2.39 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
930,000 |
930,000 |
2.02 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
930,000 |
2,363,135 |
2.31 |
% |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-04-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,000) |
487,542 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2006-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,500) |
589,594 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2006-12-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,500) |
347,632 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(100,000) |
241,062 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-12-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
128,027 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-03-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(75,924) |
124,076 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,000) |
6,000 |
0 |
- |
|
373 Records found
|
|
Page 7 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
